Yonhap Infomax NewsDec 11
Lotte Biologics, backed by Lotte Group and led by Shin Yu-yeol, launches a 277.1 billion won rights offering to fund its Songdo plant, aiming to boost its CDMO presence amid ongoing challenges in contract acquisition and track record building.
#YonhapInfomax
#LotteBiologics #RightsOffering #SongdoPlant #CDMO #ShinYuYeol
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=95097
Shin Yu-yeol-Led Lotte Biologics Secures Additional Funding for First Plant via Rights Offering—Will Its Presence Grow?

Lotte Biologics, backed by Lotte Group and led by Shin Yu-yeol, launches a 277.1 billion won rights offering to fund its Songdo plant, aiming to boost its CDMO presence amid ongoing challenges in contract acquisition and track record building.

Yonhap Infomax
Yonhap Infomax NewsNov 26
Lotte Group has replaced 20 affiliate CEOs in a sweeping executive reshuffle, appointing Shin Yu-yeol as co-CEO of its bio unit and strengthening independent management by abolishing the HQ system.
#YonhapInfomax #LotteGroup #ExecutiveReshuffle #ShinYuYeol #BioBusiness #IndependentManagement #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=92590
'Lotte Executes Sweeping Overhaul, Replaces 20 Affiliate CEOs—Shin Yu-yeol Appointed Co-CEO of Bio Unit'

Lotte Group has replaced 20 affiliate CEOs in a sweeping executive reshuffle, appointing Shin Yu-yeol as co-CEO of its bio unit and strengthening independent management by abolishing the HQ system.

Yonhap Infomax